[Form 3] ABBVIE INC. Initial Statement of Beneficial Ownership
Filing Impact
Filing Sentiment
Form Type
3
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
AbbVie Inc.
Role
EVP, Chief HR Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Option (Right to buy) | -- | -- | -- |
| holding | Option (Right to buy) | -- | -- | -- |
| holding | Common stock, $0.01 par value | -- | -- | -- |
Holdings After Transaction:
Option (Right to buy) — 5,043 shares (Direct);
Common stock, $0.01 par value — 7,048 shares (Direct)
Footnotes (1)
- Includes 1,113 restricted stock units granted under the AbbVie Amended and Restated 2013 Incentive Stock Program. These restricted stock units vest in full on February 16, 2026, and include the right to have stock withheld for tax purposes. Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 1,681 shares on 2/15/2025, and will become exercisable as to 1,681 shares on 2/15/2026 and as to 1,681 shares on 2/16/2027. Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option will become exercisable as to 1,563 shares on 2/13/2026, as to 1,562 shares on 2/13/2027 and as to 1,562 shares on 2/13/2028.
